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In 1996, the National Institute for
Occupational Safety and Health (NIOSH)
engaged more than 500 organizations and
individuals, representing labor, industry, gov-
ernment, and academia, in a process to iden-
tify occupational safety and health research
priorities for the United States. This process
identified 21 priority research areas that
became the National Occupational Research
Agenda (NORA) (NIOSH 1996). One of
these priority areas is occupational cancer
research methods. The term “research
method” has been defined to include the
range of methods, tools, approaches, and
strategies that are used in, or enable, the con-
duct of occupational cancer research. The pri-
mary reason to focus on occupational cancer
research methods is that, while there has been
an explosion of efforts to develop methods for
cancer research, these methods have not been
widely applied to resolve important issues in
occupational cancer, such as the carcinogenic-
ity of substances classiﬁed by the International
Agency for Research on Cancer (IARC) in
Groups 2A and 2B (probably and possibly
carcinogenic to humans), certain mixed-expo-
sure circumstances, and particulates. To
implement the agenda, a team of researchers
and public health professionals from industry,
labor, academia, and government deliberated
on how the methods of occupational cancer
research can be augmented, strengthened,
developed, and applied to the key issues in
occupational cancer research today. This arti-
cle contains the findings of that group, as
enhanced by peer reviews. 
The goal of this article is to identify those
methodologic enhancements that are particu-
larly applicable to occupational cancer research
and that would help generate reliable data to
support decisions impacting worker health.
Focusing on the methods of occupational
cancer research is important for a number of
reasons. First, a substantial number of cancer
deaths are related to occupational exposure.
At least 4% (24,000) of the approximate
600,000 deaths from cancer each year in the
United States is thought to be the result of
exposures in the workplace (Doll and Peto
1981). Other estimates range as high as 10%
(Landrigan and Markowitz 1989; Leigh et al.
1997). If the 4% estimate for deaths is the
same for cancer morbidity, an estimated
48,000 new cases of cancer each year have
occupational causes. This is an important
contribution to the human cancer burden,
exceeded only by the contribution of cigarette
smoking and diet. The burden of recognized
occupationally related cancer falls especially
on the minority of workers in blue collar jobs
in high-exposure industries—mining, con-
struction, manufacturing, and certain parts of
the service sector—so that the 4% or 10%
averaged over the full population is multi-
plied several-fold in these high-exposure
groups (Doll and Peto 1981; Landrigan and
Markowiz 1989; Leigh et al. 1997). Estimates
of the number of cancers related to occupa-
tional exposures are based on cancer sites
such as lung and bladder, which are recog-
nized as having a substantial occupational
component, and do not account for any
additional contribution that workplace expo-
sures play in cancers of other sites. These
limitations contribute to underestimates of
the true impact of occupational cancer.
The second reason to enhance occupa-
tional research methods is the need to identify
occupational carcinogens before widespread
human exposure occurs. Although all known
carcinogens that have been studied adequately
in experimental animals have produced posi-
tive results (Fung et al. 1995), less than 2% of
chemicals in commerce have been adequately
tested for carcinogenicity. Improved methods
are needed to prioritize chemicals for testing,
including computational and toxicologic
approaches to predicting carcinogenic poten-
tial. In particular, experimental approaches
must be adapted for evaluation of the carcino-
genicity of materials that are mixtures and to
exposure circumstances that include mixtures
of chemicals.
A third reason it is important to enhance
methods for occupational cancer research is
that there is ongoing workplace exposure to
chemicals and exposure circumstances for
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Commentarieswhich there is some evidence of carcinogenic-
ity. Of particular concern are exposures classi-
fied by IARC in Groups 2A and 2B as
possibly or probably carcinogenic to humans.
In addition, there are numerous occupations
for which an elevated risk of cancer has been
documented, but for which the causative
agent has not been definitively identified,
including painters, rubber workers, dry clean-
ers, printing processes, and welding (IARC
2001). Although occupational exposures to
many known human carcinogens (other than
tobacco smoke) have been reduced in indus-
trialized countries, Occupational Safety and
Health Administration (OSHA) permissible
exposure limits (PELs) do not exist for all
potential human carcinogens, and existing
PELs for almost all agents and substances
listed as “reasonably anticipated to be human
carcinogens” in the Ninth Report on
Carcinogens [National Toxicology Program
(NTP) 2001] are based on acute effects and
are higher than would be allowed if regulated
based on carcinogenicity. Moreover, histori-
cally the single chemical approach has been
taken to assess carcinogenicity. New methods
and strategies are especially needed to identify
carcinogenic agents in workplace environ-
ments where simultaneous or sequential expo-
sures to multiple agents exist, as is the case in
most workplace environments. Improvements
are needed in both toxicologic and epidemio-
logic methods to detect the effects of low-
level carcinogen exposures, exposures to
complex mixtures or multiple chemicals, and
potential interactions between occupational
and nonoccupational risk factors.
An important reason to enhance occupa-
tional cancer research is that occupational
cohorts often provide the best opportunity to
estimate risks associated with lower, but
much more widespread, environmental expo-
sure to carcinogens. Evidence from twin stud-
ies (Lichtenstein et al. 2000) indicates that
environmental factors may be a major con-
tributor to the development of cancer, and
the workplace is still a principal location for
environmental exposure to potentially car-
cinogenic substances. Because occupational
studies may allow individual exposures to be
estimated, data from occupational studies are
especially important for quantitative risk
assessment. Studies in occupational groups
provide a unique opportunity to understand
gene–environment interaction and other
aspects of the mechanisms by which environ-
mental exposures cause human cancer.
Occupational studies may also provide a
unique opportunity to investigate the rela-
tionship between endocrine disruptors and
cancers of the reproductive organs.
Finally, more emphasis is needed on meth-
ods for preventing occupationally related can-
cer, whether it is associated with exposure to
carcinogens or attributable to other occupa-
tional factors. Design of processes to minimize
workplace exposures to potential carcinogens is
central to prevention of occupational cancer
due to chemicals and particulates. In designing
strategies for occupational cancer prevention,
attention should also be focused on nonchemi-
cal risk factors. For example, white collar and
clerical workers have a 1.7-fold excess risk of
colon cancer related to their sedentary work, a
risk factor that may be amenable to interven-
tion strategies (Hsing et al. 1998). Moreover,
complex interactions may occur between occu-
pation and lifestyle factors such as diet, alcohol
consumption, and smoking, which contribute
to differential cancer risks by occupation.
Theoretical examples of positive interactions
include a) induction of P450 2E1 by ethanol
and nicotine, which leads to an increased rate
of metabolism of certain chemicals (e.g., vinyl
chloride) to DNA-reactive intermediates (e.g.,
chloroethylene oxide) (Ghissassi et al. 1998;
Howard et al. 2001); b) inactivation of DNA
repair processes or inactivation of the p53
gene, which will increase the carcinogenic risk
for agents (e.g., aﬂatoxin) modulated by these
proteins (Deman and Van Larebeke 2001).
Prevention research methods should empha-
size the overall reduction of cancer risks
through modification of both occupational
and nonoccupational risk factors.
More effective prevention of occupational
cancers can be accomplished by improving the
methods used in occupational cancer research.
Needs or gaps in occupational cancer research
methods have been identified in four broad
areas: identiﬁcation of occupational carcino-
gens, design of epidemiologic studies, risk
assessment, and primary and secondary 
prevention.
Identiﬁcation of Occupational
Carcinogens
Animal testing of chemicals for carcinogenic
effects. Approximately 80,000 chemicals are
available in world commerce (Fisher 1998),
and, on average, 2,000 new ones are intro-
duced each year. Testing in laboratory animals
is the main tool used for identification of
potential human carcinogens. Historically, for
many chemicals, initial evidence of cancer in
experimental animals has subsequently been
conﬁrmed by deﬁnitive human studies (Huff
1993; Tomatis 1979). Despite the utility of
testing in laboratory animals to identify
potential carcinogens and the potential to use
positive testing results to minimize or elimi-
nate human exposure, it is estimated that
fewer than 2% of chemicals in commerce have
been adequately tested for carcinogenicity.
In the United States, chemicals are tested
for carcinogenicity by government agencies
and private organizations under a variety of
circumstances. In some cases, manufacturers
of chemicals, acting alone or in cooperation
with other companies under the auspices of a
trade association or similar group, may con-
duct carcinogenicity tests. Major manufactur-
ers of some chemicals with high commercial
value such as fuel oils (Nessel et al. 1998,
1999), solvents (Green et al. 1997), or pesti-
cides (Yano et al. 2000) have conducted car-
cinogenicity tests voluntarily. For pesticides,
the U.S. Environmental Protection Agency
(EPA) may require carcinogenicity testing in
order to demonstrate that pesticides do not
pose a human cancer risk. The U.S. EPA’s
Ofﬁce of Pesticide Programs testing require-
ments are in the Code of Federal Regulations
(CFR) 40, parts 150–189, “Protection of the
Environment.” When new chemicals are
introduced into the U.S. marketplace, the
Toxic Substances Control Act (TSCA)
requires a manufacturer or distributor to sub-
mit a premanufacture notice to the U.S. EPA
90 days before marketing. Under section 5 of
TSCA, the U.S. EPA may order additional
testing, which may include cancer bioassays, if
the agency ﬁnds there is not enough informa-
tion to determine whether the material “poses
an unreasonable risk to health or the environ-
ment.” Section 4(a) of TSCA gives the U.S.
EPA the authority to require testing by indus-
try of chemicals already in commerce. TSCA
also provides for the Interagency Testing
Committee (ITC) to review chemicals in
commerce for adequacy of toxicologic data
and designates those chemicals that require
further testing, including cancer bioassays. In
practice, the U.S. EPA uses a tiered testing
approach of gene toxicity testing and sub-
chronic testing. The agency reviews these data
as well as exposure data before requiring car-
cinogenicity testing. At the present time, the
U.S. EPA has developed voluntary testing
programs in which chemical companies sub-
mit data on speciﬁed toxicologic end points to
the agency (U.S. EPA 2002a, 2002b). 
When chemical companies carry out can-
cer tests on chemicals that come under the
jurisdiction of TSCA and those tests yield
positive results, the results must be submitted
to the U.S. EPA. Submission of the data is
required under section 8(e) of TSCA. That
section also requires submission of positive
results in cancer tests of chemicals being evalu-
ated for pesticide effects but not yet registered
with the U.S. EPA, as well as new chemicals
being prepared for marketing. Health and
safety data submitted under TSCA section
8(e) cannot be claimed conﬁdential, and those
data are available to the public.
The NTP is the interagency program
responsible for chemical testing and develop-
ment of methodologies for testing. The NTP
carries out bioassays of chemicals, and NTP’s
long-term (usually 2-year) bioassays evaluate
carcinogenic potential, as well as examine
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mechanisms for toxic effects. In general,
chemicals are selected for testing when a)
there is significant human exposure, b) evi-
dence suggests potential carcinogenicity, c)
bioassays can be properly conducted with a
relevant exposure route, and d) results will be
applicable for hazard identiﬁcation, quantita-
tive risk assessment, or regulatory action. A
signiﬁcant limitation is that while workers are
often exposed to mixtures of chemicals, NTP
bioassays typically test one chemical at a time.
However, initiatives have begun to test rele-
vant mixed exposures in a laboratory setting
(Bucher and Lucier 1998).
It is clear that we need to increase and
improve carcinogenicity testing of chemicals to
which workers are exposed. Improved testing
of workplace chemicals will require a)b etter
characterization (qualitative and quantitative)
of workplace exposures; b) efforts to replicate
(or simulate) occupational exposure circum-
stances in experimental studies where appro-
priate (this recommendation does not relate to
dose but rather to route of exposure, physical
and chemical form, and common co-expo-
sures); and c) development of improved experi-
mental and computational (structure–activity)
methods that reduce uncertainty in the identi-
fication and characterization of potential
human carcinogens in a cost-effective manner.
Exposure characterization. Establishing
that a signiﬁcant number of workers or mem-
bers of the general population are or may be
exposed to a carcinogen is central to a rationale
for cancer testing. For the past 20 years, the
NIOSH National Occupational Hazard Survey
(NOHS) and National Occupational Exposure
Survey (NOES) (conducted in 1972–1974 and
1981–1983, respectively) have been driving
forces behind the testing of many occupational
agents. Those surveys are the only comprehen-
sive assessments of the number of workers
potentially exposed to chemical agents in gen-
eral industry. However, these databases are out-
dated and of questionable usefulness because
they indicate only the potential number of
workers exposed to an agent through its pro-
duction or use. The survey results do not pro-
vide information on the extent of exposure
associated with industrial processes or other
sources (e.g., combustion by-products). Due to
these limitations, the existing NIOSH surveys
leave critical gaps in estimates of exposed popu-
lations today and in the near future (Lucier and
Schecter 1998). Recognizing this, NIOSH
plans to update the NOES with hazard surveil-
lance in high-risk industries and occupations
(Boiano and Hull 2001).
To adequately estimate the number of
workers potentially exposed to speciﬁc chemi-
cals or mixtures, methods are needed to com-
bine available information about chemical
production and potential release into the
workplace environment with data on employ-
ment, job categorization, and manufacturing
processes. Research is also needed to character-
ize occupational exposures to aid in the design
of occupationally relevant exposure studies. A
good example of such research is the recently
established collaboration between NIOSH and
the National Institute of Environmental
Health Sciences to assess the inhalation toxic-
ity of cellulose ﬁbers. NIOSH is characterizing
human exposures in the workplace by deter-
mining dose, dimension, and type of cellulose
ﬁbers. This information will serve as a basis for
the NTP’s experimental testing procedures.
Experimental exposures. It would be help-
ful for experimental studies to be conducted in
a manner that reﬂects occupational exposure
circumstances. Several issues need to be
addressed in designing experimental exposures.
Extrapolation to humans is facilitated when
animal studies are conducted using the same
routes as occur for human exposures. Complex
mixtures such as welding or asphalt fumes,
metal-working ﬂuids, diesel particulate matter,
and synthetic ﬁbers are not readily character-
ized for the purpose of producing standardized
test materials that are needed for bioassays. A
worker’s cancer risk may be affected by
whether he or she is exposed to a single agent
or has multiple (mixed) exposures. In one sce-
nario, simultaneous exposure to a complex
mixture of potential cancer-causing or modify-
ing agents might arise from a single source,
such as the combustion of organic material.
Another exposure scenario may involve simul-
taneous or sequential exposure to two or more
cancer-causing or modifying agents from sepa-
rate sources. Exposure to single versus multiple
agents may result in tumor induction at the
same target organ and/or different ones. These
scenarios reﬂect the need to consider potential
interactive effects and to ascertain if the risk
from exposure to multiple agents differs from
what would be expected on an additive basis of
the individual components. It is critically
important to evaluate the impact of each con-
stituent of a mixture on the other constituents’
roles in the process of carcinogenesis. For
example, one agent may induce or inhibit
enzyme activities that affect the tissue concen-
tration of the active intermediate of a second
agent, or the first agent may inhibit critical
repair processes (e.g., DNA repair), resulting in
increased potency of other carcinogenic agents
in the mixture. Conceivably, chemical interac-
tions that are not evident at occupational expo-
sure levels may result at exposure levels used in
some animal bioassays.
If workers are exposed to a mixture, car-
cinogenicity studies of the mixture itself may
be an efﬁcient ﬁrst step, particularly where it is
uncertain which, if any, components might be
carcinogenic. Testing individual components
can be critical in identifying the primary 
carcinogenic agent or agents in the mixture,
assuming that human exposure to the mixture
cannot be eliminated. However, testing com-
plex mixtures presents formidable scientific
problems. When a mixture is tested, it is
important that the composition of the mixture
be similar to what occurs in the workplace, but
this may not be easy to achieve because prod-
ucts of individual processes (i.e., combustion
of organic materials) may vary depending on
reaction parameters such as temperature, as to
both identity and relative quantities of mixture
constituents. An example of properly charac-
terizing occupational exposures and reproduc-
ing these exposures under experimental
conditions is an ongoing study of asphalt
fume. NIOSH, in conjunction with the
Asphalt Institute, is developing and testing an
asphalt-fume–generating system that simulates
road paving conditions to assess the toxicity
and carcinogenic potential of the asphalt fume
in animal inhalation studies. Comparable
methodologies are needed for such mixtures as
welding fumes, metalworking fluids, fibers
and dusts, and combustion products. All of
these complex exposures pose different prob-
lems that will require unique solutions.
Strategies must also be developed to pre-
dict potential adverse effects of mixtures
(Haddad et al. 1999). This includes strategies
for identifying which mixtures merit most
consideration for testing and how testing
should be accomplished. The value of such a
strategy depends on its ability to use data
from tests of one mixture to predict effects of
exposure to a new but similar mixture. An
alternative approach could involve the devel-
opment of mechanism-based dose–response
models through an iterative process of design-
ing experiments, conﬁrming that model.
Experimental methods and models. The
chronic exposure rodent bioassay, as con-
ducted by the NTP, is the international stan-
dard for identifying chemical carcinogens
(Fisher 1998). To date, no human carcinogens
have produced negative ﬁndings in this bioas-
say (IARC 1999a). However, in many cases,
data from epidemiologic studies are not sufﬁ-
cient to provide direct conﬁrmation of carcino-
genicity in humans of chemicals shown to
cause cancer in animals. In the absence of sufﬁ-
cient human data, the NTP Report on
Carcinogens (NTP 2001) describes such
agents as “reasonably anticipated” to cause can-
cer in humans, while the IARC Monograph
program (IARC 1999a) describes such agents
as “probably” or “possibly” carcinogenic in
humans, depending on supporting data.
Data gaps in our knowledge of chemical
carcinogenicity create uncertainties in quanti-
tative extrapolations of animal findings to
human risk at occupational exposure concen-
trations. Additional data and better risk
assessment models are needed that accurately
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interindividual differences in sensitivity, as
well as differences in exposure circumstances.
Quantitative information on the effects of
carcinogen exposure at the cellular and molec-
ular levels will be critical to developing biolog-
ically based dose–response models that could
strengthen the scientiﬁc basis for extrapolation
of animal ﬁndings to humans.
Genetically altered mice are being evalu-
ated as possible replacements for, or adjuncts
to, conventional rodents for bioassays of chem-
ical carcinogenesis (Donehower et al. 1992;
Leder et al. 1990; Yamamoto et al. 1996).
Interest is high in using transgenic mice to
identify cancer-causing agents because bioas-
says in transgenic mice may be performed
more rapidly and with less expense than the
conventional 2-year rodent study (Eastin
1998). Some researchers speculate that these
models show preferential responses to trans-
species carcinogens and are better suited to
identifying human carcinogens because they
already possess altered genes known to be
involved in human cancers (Tennant 1998).
There is also a concern about interpretation of
negative results in animals that are observed
for only a fraction of their potential life span.
The transgenic carcinogenesis testing systems
must be validated against known and proba-
ble human carcinogens if they are to provide
data useful for risk assessment. These models
must be shown to be responsive to agents that
are likely to be weak carcinogens in humans.
Also, methods are needed for estimating
human risk from carcinogenicity data
obtained in transgenic mice.
In the past decade, interest has grown in
developing computer programs that use struc-
ture–activity relationships to identify potential
carcinogens. These systems rely on two gen-
eral approaches (Richard 1998). The first
approach, which examines statistical correla-
tions between structure and activity, is used by
the computer programs TOPKAT (Accelrys,
Burlington, MA) and CASE/MULTICASE
(Multicase Inc., Beachwood, OH). The sec-
ond approach, which is knowledge-based and
relies on expert judgment for developing pro-
gram rules, is used by DEREK (Lhasa Limited,
Leeds, UK), OncoLogic (Logichem, Inc.,
Boyertown, PA), and METEOR (Lhasa
Limited). Although these methods show con-
siderable promise, predictions must be demon-
strated to approach the reliability of animal
testing if the methods are to be used to reach
conclusions about the carcinogenicity of chem-
icals. A model approach is the NTP challenge
to predict the results of 2-year rodent-cancer
studies in progress (Bristol et al. 1996, 1997;
Wachsman et al. 1993). Such efforts should
be expanded, and modeling methods should
be more uniﬁed in their approach. Chemicals
shown to be potentially carcinogenic based
on structure–activity relationships, shown to
be positive in short-term tests, or predicted to
be negative based on computer models
should be tested in long-term animal studies
to validate these approaches and to obtain
dose–response data.
An important enhancement to current
efforts to identify potential carcinogens is to
develop a data resource that provides users
with information on chemical structure–activ-
ity relationships and toxicologic testing results
(Richard 1998). Often, toxicologic test results
are not published in the peer-reviewed litera-
ture and are not accessible to those building
and evaluating predictive models. The possibil-
ity of establishing such a data resource should
be explored, with attention to methodologic
issues such as minimal technical requirements
for studies to be included and conﬁdentiality
concerns related to proprietary research.
Epidemiologic Study Methods
Over the years, epidemiology has played the
leading role in associating exposures to chem-
icals with development of cancer in humans.
Historically, clinicians were the ﬁrst group to
recognize occupational cancers. Early reports
identiﬁed elevated scrotal cancer in chimney
sweeps (Pott 1775), lung cancer in uranium
miners (Harting and Hesse 1879), and uri-
nary bladder cancers in dye industry workers
(Rehn 1895). In the early to mid-1900s,
methods evolved for conducting epidemio-
logic cohort studies (Samet and Munoz
1998), and were applied to the analysis of
mortality in occupational cohorts. Early occu-
pational cohort studies documented the asso-
ciation of exposure to β-naphthylamine and
benzidine with bladder cancer (Case et al.
1954), arsenic with lung and skin cancer
(Hill and Faning 1954), and asbestos with
lung cancer and mesothelioma of the chest or
peritoneum (Doll 1955).
In parallel with the development of meth-
ods to elucidate the relationships between
chemical exposures and cancer in humans, the
foundation for study of chemical carcinogene-
sis in animals was established in the early twen-
tieth century (Cook et al. 1932; Kennaway
1934; Yamagiwa and Ichikawa 1915). In
1968, a formal animal bioassay program was
established at the National Cancer Institute,
and by 1978, 356 chemicals had been entered
into testing (Epstein 1979). The development
of experimental models for carcinogenesis and
the passage of the Occupational Safety and
Health Act in 1970 stimulated tremendous
activity in occupational cancer epidemiology in
the 1970s and 1980s. While case reports and
reports of workplace “cancer clusters” contin-
ued to provide impetus for epidemiologic
studies, positive ﬁndings in animal bioassays
stimulated increasingly systematic efforts to
identify occupational cohorts for study.
Occupational cohorts often provided the best
opportunity to evaluate the risk of cancer from
chemicals that have been found to be animal
carcinogens because personnel records allowed
identification of persons who had been
employed decades earlier, and occupational
exposures were often orders of magnitude
higher than those experienced elsewhere. 
Occupational cohort studies initiated in
the 1970s and 1980s were invaluable in docu-
menting the effects in humans of exposure to
asbestos, benzene, beryllium, bis-chloromethyl
ether, vinyl chloride, and other widely used
chemicals and environmental contaminants
(IARC 1987). More recently, population-
based case–control studies began to focus on
occupational factors (Siemiatycki et al. 1987).
These studies have provided data on potential
interactions between occupational and nonoc-
cupational exposures and allowed estimation
of the proportion of lung, bladder, and other
cancers that can be related to occupational
factors (Doll and Peto 1981; Silverman et al.
1989a, 1989b; Simonato et al. 1988).
By the late 1990s, a widespread perception
existed that the scientific and public health
importance of investigations of workplace-
related cancer had diminished. This perspec-
tive likely stemmed in part from the belief
that most major occupational carcinogens
have already been identified. However, the
absence of epidemiologic data for many ani-
mal carcinogens (including some common
workplace exposures) suggests that this con-
clusion may be premature (Blair et al. 1999).
Epidemiologic studies remain critically impor-
tant in the prevention of occupational cancer,
and studies in occupationally exposed groups
have signiﬁcant potential to contribute to the
understanding of risks from carcinogenic
chemicals for the general population. The
development of better tools for conducting
epidemiologic studies is needed to identify
exposed populations for study, measure expo-
sure–response relationships, and identify, vali-
date, and utilize measurable intermediate
outcomes (early disease biomarkers) rather
than cancer incidence or death from cancer.
The strengths and limitations of occupa-
tional cancer epidemiology were highlighted
by Karstadt (1998), who reviewed IARC eval-
uations of carcinogens, as presented in the
IARC Monographs. As of 1999, occupational
studies had led to IARC’s classiﬁcation of 38
chemicals with industrial uses as Group 1
(known human carcinogens). In addition,
many other industrial chemicals are in IARC
Groups 2A and 2B, “probably” or “possibly”
carcinogenic to humans, respectively, which
usually indicates they have “sufficient” evi-
dence for carcinogenicity in animals, but less
than sufﬁcient evidence from human studies.
Many of the industrial agents classiﬁed in
Groups 2A and 2B have been the subject of
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epidemiologic study, with lack of success
attributable to inadequate cohort size, latency,
or exposure information. Many industries use
structurally related chemicals, and a great deal
of substitution of chemicals has occurred over
time. For example, in the dye manufacturing
industry, it has been difficult to identify a
cohort exposed to an aromatic amine such as
o-toluidine but not exposed historically to
known bladder carcinogens such as β-naph-
thylamine or more recently to benzidine-
based dyes. Assembling cohorts for studies of
chemicals, such as dry cleaning solvents, that
are used in small businesses has also been dif-
ﬁcult. Several occupational groups, including
painters, hairdressers, and dry cleaners, are
known to have increased risks of cancer, but
the link between cancer and specific chemi-
cals for these groups has not been definitely
established.
Exposure assessment. Exposure assessment
plays a central role in occupational cancer epi-
demiology. An exposure–response relationship
within a cohort is powerful evidence that an
agent is carcinogenic. Exposure assessment pre-
sents a major challenge because the exposure
period of interest is usually 10–50 years before
the onset of cancer. In many industries, quan-
titative exposure data are available only for
recent decades. Retrospective exposure assess-
ment requires precise knowledge about how
production processes and exposure controls
changed over time. Detailed exposure assess-
ment may not be feasible for many studies,
either because of insufﬁcient historic exposure
data or because work histories and job titles are
not sufficiently detailed. For these reasons,
many epidemiologic studies of occupational
cancer have been able to analyze outcomes
only by duration of employment or by assign-
ment to specific jobs or departments, which
are qualitative surrogates for exposure data
(Stewart and Herrick 1991). Even when quan-
titative exposure–response data are generated,
variability of exposure among workers in an
exposure group, and among exposures for an
individual worker day-to-day, present obstacles
to observing exposure–response relationships.
Development of methods for reconstruct-
ing retrospective (historical) exposures in
cohort and case–control studies was a focus of
research in the 1990s. Progress was made in
that area, as exemplified by a number of
cohort studies for which historical exposure
estimates have been successfully developed
and used in exposure–response analyses,
including studies of dioxin (Piacitelli et al.
2000; Steenland et al. 1999), acrylonitrile
(Blair et al. 1998; Stewart et al. 1998),
formaldehyde (Blair et al. 1990; Gardner et
al. 1993), diatomaceous earth (Checkoway et
al. 1997), benzene (Hayes et al. 1997; Rinsky
et al. 1987), vinyl chloride (Simonato et al.
1991), and 1,3-butadiene (Macaluso et al.
1996). High-quality historical exposure
reconstruction is technically demanding and
time-consuming. Investigators at NCI and
NIOSH are attempting to develop standard-
ized methods for retrospective exposure
assessment in cohort studies, but to what
degree those methods will be suited to the
wide variety of exposures and exposure cir-
cumstances across the industrial spectrum is
still unclear (Stewart et al. 1999).
Retrospective exposure assessment in pop-
ulation-based case–control studies is difﬁcult
because often the only data available are job
title, type of industry, and dates of employ-
ment, as reported by a study subject or the sur-
vivor of a deceased subject. However, data
collection methods in case–control studies
have improved in the past 20 years to allow
collection of more exposure information
(Gerin et al. 1985; Stewart et al. 1996). Newer
assessment methods enable researchers to esti-
mate exposures to individual chemicals or
groups of chemicals over a working lifetime or
during speciﬁc periods of employment. These
approaches involve a combination of asking
detailed questions tailored to specific jobs
(job-specific modules) and applying expert
knowledge to develop exposure estimates.
In the future, epidemiologic studies
(whether cohort or case–control) are likely to
rely on data generated from exposure estima-
tion models whenever actual measurements
of exposure are unavailable, unreliable, or
otherwise limited in utility. The models will
incorporate factors called “determinants of
exposure,” which should increase the accuracy
and reliability of exposure estimates. Research
is needed to identify which determinants of
exposure are important under which circum-
stances, and to use empirical data to validate
exposure estimates based on models. Because
the exposure estimates in case–control studies
are largely based on questionnaire responses,
additional research is needed on the validity
and reliability of questionnaires used in the
collection of occupational history information.
Exposure assessment is particularly difﬁcult
for substances that may be absorbed through
the skin. Although air concentrations of chem-
icals are routinely measured, quantitative infor-
mation from which to determine dermal
exposure potential is either limited or nonexis-
tent for most chemicals and workplaces. Even
when data on surface contamination levels are
available, those data are difficult to correlate
directly with human exposure. Methods for
detecting dermal contact with chemicals, such
as patch samples attached to work clothing and
hand wash samples, are often of limited utility
because they are difﬁcult to relate to absorbed
dose and may interfere with estimation of
exposure through all routes by biological mon-
itoring. Moreover, few data are available on the
potential for absorption through intact or bro-
ken skin of a large number of chemicals used
in industry. Strategies are needed to identify
which potential occupational carcinogens can
be absorbed through the skin, especially those
for which skin absorption may represent a
major exposure route. Methodologic needs
include structure–activity models, well-vali-
dated in vitro and in vivo test systems to pre-
dict skin penetration in humans, and methods
to measure the extent of dermal absorption of
chemicals in the work environment (Boeniger
and Lushniak, 2000).
The need is especially pressing for better
methods to quantify the total dose received
by workers through all routes of exposure to
workplace chemicals. Development of biolog-
ical markers of exposure, as well as an under-
standing of metabolism of occupational
chemicals in humans, will be critical to
improving dose estimation for chemicals with
signiﬁcant dermal absorption potential.
Scientists had hoped that biological mark-
ers of exposure would contribute to historic
exposure reconstruction over a working life-
time, but to date their utility in this regard has
been limited. Most biological markers do not
reﬂect exposures acquired over long periods of
time. Many chemicals have relatively short
half-lives in humans, and even those that bind
to hemoglobin or DNA in various tissues are
present only for the life span of the target cell.
A fruitful approach has been to use specimen
banks holding historic blood specimens to
provide data for retrospective exposure analy-
sis for substances with longer half-lives, such
as organochlorines (Hoyer et al. 2000; Ward
et al. 2000; Wolff et al. 2000) as well as non-
Hodgkin lymphoma (Rothman et al. 1997).
Epidemiologic study designs. Retrospective
cohort studies have played an important role in
identifying occupational carcinogens, but iden-
tifying suitable populations for such studies is
often not possible. Even for widely used chem-
icals, identifying study populations with ade-
quate sample size, good work-history records,
and a minimum of confounding exposures
may be difﬁcult. The problem of limited pop-
ulation size may in some cases be overcome by
conducting multinational studies with data
collection standardized across countries and
combined into one large cohort for analysis.
The Environmental Epidemiology Unit at
IARC has coordinated a number of these types
of studies; recent examples include studies of
workers exposed to phenoxy herbicides,
chlorophenols, and dioxins (Kogevinas et al.
1997), styrene (Kogevinas et al. 1994), and
and vinyl chloride (Ward et al. 2001). Better
methods must be developed for identifying
occupational groups suitable for cohort studies
using existing databases compiled for other
purposes, and accessing and utilizing informa-
tion from labor and industry organizations.
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be identiﬁed, alternatives should be considered,
including prospective cohort studies, case–con-
trol studies, and studies using intermediate
markers as end points. Prospective cohort stud-
ies are particularly useful for studying exposures
that are difﬁcult to ascertain from records or
from recall. This design allows for periodic col-
lection of both exposure and health outcome
data and potential banking of biologic speci-
mens. Nested case–control studies may be con-
ducted within prospective cohort studies and
may be particularly efﬁcient in studies where
costly analyses of biological specimens are
needed. This design is amenable to studying
the relationship between genetic factors, exoge-
nous exposures, and cancer outcome.
Prospective cohort studies are expensive
and time consuming, but they may be cost
effective, especially as multiple outcomes can
be evaluated. Few examples exist of prospective
cohort studies established primarily for evalu-
ating effects of occupational exposures on can-
cer occurrence. One such investigation is the
Agricultural Health Study, which is a cohort of
more than 90,000 North Carolina and Iowa
pesticide applicators and their spouses
(Alavanja et al. 1996). This study focuses on a
narrowly defined occupational group [com-
mercial and private pesticide applicators
(farmers) and farmers’ spouses] and provides
considerable statistical power to examine the
association between development of cancer
and exposure to numerous agricultural chemi-
cals. Additionally, buccal cavity cells are being
collected for use in studying genetic factors.
General population case–control studies of
associations between cancer and occupation
can be advantageous in terms of cost, feasibil-
ity, and time needed to carry out the investiga-
tion. Case–control studies can be incidence
based, typically feature more accurate cancer
diagnoses than cohort mortality studies,
include small as well as large workplaces, and
provide opportunities to assess a broad spec-
trum of risk factors and how they interact with
each other (Blair et al. 1999). Case–control
studies also provide better opportunities to col-
lect biological samples because, unlike most
retrospective cohort studies, many involve
direct contact with study subjects. These speci-
mens are particularly useful in assessing genetic
polymorphisms because constitutive DNA will
not be affected by disease status.
The principal limitation in case–control
studies has been the reliance on data from
questionnaires to assess occupational expo-
sures. Methodologic research is needed to
improve exposure estimation in case–control
studies. Also, better methods must be devel-
oped for rapid case ascertainment for studies
of cancers with poor survival because proxy
interview information may be especially poor
for workplace exposure information. Methods
also are needed for evaluating the potential for
and correcting response bias in case–control
studies and for assessing disease and treatment
effects on biologic measures of exposure.
Case–control studies to evaluate relation-
ships between cancer occurrence and occupa-
tional exposures must be large enough to have
adequate statistical power to detect associations
for less common occupations and exposures.
Consequently, multicenter studies are often
necessary to obtain a large enough sample in a
reasonable time frame. International studies
have made important contributions by allow-
ing sufﬁcient statistical power to examine less
common histologic types (Fortuny et al. 1999)
and exposure–response relationships in great
detail (Agudo et al. 2000). One way to increase
the efﬁciency of case–control studies of cancer
is to study multiple sites under a similar proto-
col and use a common control group.
Cross-sectional studies and early biologic
effect (intermediate effect) biomarkers. Cross-
sectional studies of intermediate end points in
healthy worker populations exposed to known
or suspected carcinogens have been carried out
for many decades. The goals of such studies are
to provide mechanistic insight into the early
biologic effects of a given exposure and at the
same time, either implicitly or explicitly, to
evaluate the potential future risk to study sub-
jects, at least at the group level. Given that can-
cer incidence and mortality data have limited
utility for cancer prevention because they are
discernable only after workers have been
exposed, disease has developed, and people
have died, cross-sectional studies of intermedi-
ate end points in healthy workers can play an
important role in the timely evaluation of car-
cinogenic risk. IARC has given credence to the
results of such studies in its more recent evalu-
ations of several suspect occupational carcino-
gens. For example, human genotoxicity data
were used by IARC to upgrade ethylene oxide
to a known human carcinogen (IARC 1994).
A wide variety of intermediate end points
have been studied in occupational studies of
workers exposed to a long list of chemical
agents. These include biological markers of
DNA damage (e.g., DNA adducts in periph-
eral white blood cells or other accessible targets
such as exfoliated urothelial cells (Groopman
and Kenslar 1999; Wild and Pisani 1998) and
chromosomal damage (e.g., chromosomal
aberrations in cultured peripheral lymphocytes
(Tucker et al. 1997). Intermediate markers
may reflect biologic changes further down-
stream from exposure that result in altered
structure or function, such as elevated p53 in
blood of vinyl chloride workers (Trivers et al.
1995). Although much of this work has
focused on biomarkers that reﬂect genotoxic
effects, increasingly studies are evaluating
potential carcinogens that may exert their
action through more subtle mechanisms, such
as alteration of immune function or the hor-
monal milieu. At the same time, new biotech-
nology approaches that can be applied to
accessible tissue of healthy workers exposed to
agents of concern hold the promise of provid-
ing more extensive insight into cytogenetic and
somatic mutation patterns, changes in mRNA
expression, and alterations in the type and lev-
els of proteins. Applying these new methods,
both in experimental systems and where
appropriate in exposed worker populations, to
the study of potential occupational carcinogens
should be a high priority.
Although cross-sectional studies can be
useful in providing mechanistic insight into
the early biologic effects of particular com-
pounds in exposed workers, their direct appli-
cation to the risk assessment process is far
more challenging. For an intermediate end
point to play a role in the later process, par-
ticularly at the semiquantitative or quantita-
tive level, evidence must be provided that the
biologic marker reﬂects processes that are on
the causal pathway or that are good surrogates
for events occurring on the causal pathway
from the exposure to disease.
Both prospective animal studies and
human studies can be used in this process.
Priority should be given to methods for
incorporating intermediate markers into
long-term bioassays because these studies
involve prospective followup of relatively
large numbers of laboratory animals. At the
same time, opportunities should be sought to
evaluate the quantitative relationship between
intermediate markers and subsequent cancer
risk in humans through calculation of the eti-
ologic fraction of the disease attributable to
particular levels of the biomarker (Schatzkin
et al. 1990; Schulte and Rothman 1998).
Validation of biomarkers in humans often
requires following large populations for long
periods. For some biomarkers, the temporal
criterion can be satisﬁed by analyzing banked
biological specimens in cohorts whose cancer
incidence can be ascertained through linkage
to outcome registries or other procedures
(however, this cannot be done for some
important markers that must be analyzed in
fresh tissue). Although the issue of validation
of intermediate effect biomarkers is not
unique to occupational groups, worker popu-
lations under medical surveillance (because of
their high risk of certain cancers) may offer
opportunities to evaluate the predictive ability
of intermediate biomarkers. Unfortunately,
there has been little work on evaluating the
relationship between intermediate biomarkers
and cancer risk in occupational groups or in
the general population. One exception is a
series of general population cohort studies
that provided evidence that chromosomal
aberrations in peripheral lymphocytes are
associated with increased risk of subsequently
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Hagmar et al. 1998; Liou et al. 1999).
A recent study combined data from two of
these cohorts and showed that the relationship
between chromosomal aberration frequency
and cancer risk did not differ by smoking sta-
tus or in regard to exposure to various occupa-
tional carcinogens (Bonassi et al. 2000). This
ﬁnding suggests that chromosomal aberration
frequency integrates a variety of genotoxic
exposures as well as genetic susceptibility and
might be a general marker of cancer risk.
These original ﬁndings need to be conﬁrmed
and extended (the number of cases was too
small to estimate cancer site-speciﬁc risks with
precision). In addition, this type of research
needs to be supported to develop a wider range
of valid intermediate biomarkers that can be
used in cross-sectional studies of workers
exposed to various types of suspected carcino-
gens. Also, further work is needed to identify
and evaluate intermediate biomarkers that may
be speciﬁc for particular exposures and for spe-
ciﬁc cancer sites and to prioritize biomarkers
for developmental and validation studies.
Host factors and gene–environment inter-
actions. In 1775, Sir Percival Pott described a
high frequency of scrotal cancer among chim-
ney sweeps exposed to coal tar, establishing
one of the first links between occupational
exposure and cancer. Less well known is the
hypothesis put forward several decades later
that because not all chimney sweeps exposed
to soot developed this cancer, constitutional
factors might also play a role in the etiology
of this condition (Waldron 1983). As the
genetic basis for biological responses to envi-
ronmental and occupational exposures is
becoming increasingly understood, it is clear
that interindividual variation in susceptibility
and the genetic repair process may play roles
in the development of occupational as well as
nonoccupational cancers (Ishibe and Kelsey
1997; Nakajima and Aoyama 2000).
Advances in genetic research are being
propelled ever more rapidly through the use
of new tools derived from the Human
Genome Project. For example, a completed
first draft of a working transcript of the
human genetic code was recently announced
(U.S. Department of Energy 2001). The
Human Genome Project will ultimately pro-
vide a working transcript of the human
genetic code. A large part of the subsequent
effort will be to deﬁne human disease suscep-
tibility in terms of DNA sequence variation.
Armed with the tools furnished by the
genome project, epidemiologic studies will be
able to more efficiently investigate genetic
susceptibility to disease. The analytical tools
to evaluate genetic parameters are available.
Robotics and test design [TaqMan (Applied
Biosystems, Foster City, CA), Gene-Chip
(Affymetrix, Inc., Santa Clara, CA), and
automated DNA sequence determination]
have made it possible to carry out rapid
analysis of large numbers of samples using
“high sample through-put” testing schemes.
There are several reasons that incorporat-
ing the study of common genetic polymor-
phisms into epidemiologic studies should
enhance our understanding of the relationship
between occupational exposure and cancer.
First, application of genetic risk factors into
studies of cancer (or validated intermediate
end points) caused by known occupational car-
cinogens can provide a powerful approach to
understanding the basic biological mechanisms
of disease and may lead to better techniques
for cancer prevention. Second, evaluation of
the relative risk for suspect exposures within
subgroups defined by biologically important
genetic variants may clearly identify carcino-
gens that have small, equivocal risks in the
overall worker population and may lead to
more meaningful risk assessment and imple-
mentation of policies and standards that pro-
tect the most vulnerable members of the
workforce. Third, the demonstration that
polymorphisms in genes that carry out expo-
sure-speciﬁc metabolic functions interact with
complex mixtures to cause cancer may help
clarify which components of such mixtures are
the key carcinogens. Finally, by identifying
genetic polymorphisms associated with a given
cancer, one may generate insights into the
potential carcinogens acted upon by these gene
products (Rothman et al. 2001).
For the same reasons that studies in occu-
pational groups were useful for identifying
human carcinogens, occupational groups
with established or potential cancer risks may
provide ideal populations in which to investi-
gate the effects of genetic susceptibility to
environmental carcinogens. However, con-
ducting workplace-based studies related to
genetic susceptibility to occupational carcino-
gens requires consideration of ethical, legal,
and social issues. Legitimate concerns have
been raised on the part of workers and their
advocates about the potential ramiﬁcations of
genetic susceptibility research for employ-
ment discrimination, workers’ compensation,
and insurability (Samuels 1998). Complex
questions arise concerning the ability of
researchers to safeguard the conﬁdentiality of
genetic data. These are serious concerns that
must be addressed in each study. At the same
time, it is unlikely that genetic information
concerning workplace cancer risk will ever be
sufficiently informative to be relevant to the
individual for use in genetic testing per se.
This is because, based on studies carried out to
date and on theoretical grounds, such com-
mon polymorphisms pose small to modest rel-
ative risks and are likely to have very low
absolute risks (i.e., penetrance) (Rothman et
al. 2001). Rather, the incorporation of genetic
susceptibility markers into epidemiologic
studies will have its most signiﬁcant impact in
the development of better laboratory model
systems, toxicogenomics and proteomics,
improved risk assessment, intervention and
prevention, and ultimately ensuring that the
workplace is safe for all workers.
Methods to evaluate occupational cancer
among women and minorities. In 1997,
approximately 60 million women and 10 mil-
lion nonwhite men were employed outside the
home in the United States, accounting for
46% and 7%, respectively, of the employed
civilian workforce (Bureau of Labor Statistics
2001). Most epidemiologic research on occu-
pational cancer, however, has focused on
white men (Zahm et al. 1994). Although we
assume risks identiﬁed in white men also per-
tain to women and minorities, studying
women and minorities specifically is impor-
tant for several reasons. The frequent occur-
rence of mammary and reproductive tumors
in rodent bioassays (Dunnick et al. 1995;
Griesemer and Eustis 1994) indicates these
sites may be particularly susceptible to occupa-
tional carcinogens. Women and minorities
may respond differently to occupational expo-
sures than white men because of anatomic,
metabolic, genetic, or other differences. They
may also experience hazardous occupational
exposures in recently developed industries,
such as electronics, that have not yet been
fully evaluated for cancer risks among white
men. Women and minorities may have work-
place exposures different from those of white
men. Most exposure measurement data have
been generated from studies of men, and few
studies have estimated variability in exposure
measurements based on sex, race, ethnicity, or
related variables. The same external exposure
may result in different internal dose because of
sex-specific absorption, distribution, kinetic,
and metabolic rates (Greenberg and Dement
1994) or may vary between racial and ethnic
groups because of differences in the frequency
of metabolic polymorphisms. Studying expo-
sure variability by sex, ethnicity, and race may
help to design intervention and prevention
strategies and to more accurately estimate
exposure for epidemiologic studies.
Epidemiologic research on occupational
cancer among women and minorities has been
hampered by methodologic problems. The
most important obstacle is that, in general,
only a small number of women and minorities
are employed in jobs of interest in any given
study. Although many industrial cohorts
assembled for study of potential occupational
carcinogens in the past have included few
women because of historic employment pat-
terns, some hazardous occupations now have
large female workforces.
Every effort should be made to fully use
the data on women and minorities in all
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that have substantial numbers of women and
minorities but do not have sex- and race-spe-
cific analyses. To overcome methodologic
problems associated with small numbers of
women and minorities in specific job cate-
gories or industries, studies of occupational
cancer among women and minorities should
focus on exposures to individual chemicals or
mixtures of chemicals across job categories
and industries. Whether sex, race, and ethnic-
ity should be taken into account in exposure
assessment must be evaluated. If so, appropri-
ate methodologies should be developed.
Setting priorities for epidemiologic studies
in worker populations. One approach to set-
ting priorities for cancer studies in occupa-
tional cohorts has been to target exposures
classiﬁed by IARC in Groups 2A and 2B for
which there is widespread human exposure.
Recent changes in criteria for evaluation of
animal bioassay data by IARC and other agen-
cies suggest an additional priority area for epi-
demiologic research. The IARC Monograph
program, the NTP, and the U.S. EPA have
developed criteria by which tumors arising in
certain organs or through certain hypothesized
mechanisms in animals are judged not to be
relevant to humans. Use of these criteria by
IARC, for example, has resulted in chemicals
for which there is “sufﬁcient evidence for car-
cinogenicity in animals” being classified in
Group 3, “not classiﬁable as to carcinogenicity
in humans” (Karstadt and Haseman 1997).
For some of these chemicals, including
diethylhexyl phthalate (IARC 2000) and
atrazine (IARC 1999b), direct information on
the biological activity in humans has been
limited. Methods should be developed to
examine relevant intermediate end points in
humans to verify or refute assumptions about
mechanism, as well as to evaluate cancer risks
in exposed populations.
Methods for studying the association
between parental occupation and childhood
cancer in offspring. Since the early 1980s, sev-
eral reports have been published on the rela-
tionship between parental occupational
exposures and the risk of childhood cancer in
offspring (Colt and Blair 1998; Kristensen et
al. 1996; Savitz and Chen 1990). These stud-
ies, which have been mostly case–control in
design and focused on paternal occupation,
have reported associations between a variety of
occupations and exposures and diverse cancers.
Relatively consistent associations have been
noted for motor vehicle-related occupations,
painters, metal workers, solvent workers, and
pesticides applicators and the risk of childhood
cancers such as leukemia and central nervous
system tumors (Colt and Blair 1998; Daniels
et al. 1997; Savitz and Chen 1990; Zahm and
Ward 1998). However, current epidemiologic
evidence is insufﬁcient to determine the causal
relationship, if any, between parental occupa-
tion and risk of cancer in offspring. The major
limitation has been the ascertainment and eval-
uation of occupational exposures. Recent
case–control studies have been able to evaluate
more etiologically homogeneous subgroups
due to larger study sizes and use of biologic
and molecular markers (Robison et al. 1995).
The use of job-speciﬁc modules for the collec-
tion of work histories and other advances dis-
cussed earlier are being used to improve the
quality of exposure assessment in case–control
studies of childhood cancer as well. In addi-
tion to incorporating more reﬁned methods to
estimate occupational exposures, future stud-
ies should use sensitive techniques to detect
the effects of occupational chemical exposures
on the placenta, fetus, and germ cells; for
example, assays of DNA damage by fluores-
cence in situ hybridization. Advancement in
this area will require multidisciplinary research
by epidemiologists, industrial hygienists, toxi-
cologists, and molecular biologists.
Surveillance. Improved methods could
enhance the ability of surveillance programs to
detect occupationally related cancer. Cancer
surveillance systems have been developed by a
few large companies. A useful resource for
occupational cancer surveillance is the
National Occupational Mortality Surveillance
System (NOMS), which has coded occupa-
tion and industry on death certiﬁcates in 27
states over a 10-year period. These data have
been used to explore occupational associations
with health outcomes (Burnett and Dosemeci
1994; Loomis and Savitz 1991; Cocco et al.
1999a, 1999b; Krstev et al. 1998) and to
investigate etiologic associations (Loomis et al.
1994). Methods should be explored to con-
duct occupational cancer surveillance through
cancer registries because it has several advan-
tages. These include the ability to detect associ-
ations with less fatal cancers and to examine
associations with histological subtypes.
Methods should be developed for hospitals to
collect and code occupational data in a stan-
dardized way to facilitate data collection by
cancer registries. In addition, cancer surveil-
lance by speciﬁc companies could be enhanced
by methods to use information routinely col-
lected for insurance purposes, with appropriate
attention to privacy and conﬁdentiality.
Improvements in Risk
Assessment
Risk assessment is a process that uses available
scientiﬁc information on the properties of an
agent and that agent’s effect on biological
processes to evaluate the potential for harm as
a consequence of exposure to that agent.
Occupational cancer risk assessment might be
considered a more speciﬁc application of the
process, focusing on whether a particular
workplace exposure would result in cancer.
Risk assessments in general are organized
into four components: hazard identiﬁcation,
exposure–response assessment, exposure
assessment, and risk characterization. The ﬁrst
three components answer the questions of
whether an occupational insult may cause can-
cer, at what exposure level this may occur, and
what occupational exposure level exists in the
population. Risk characterization integrates
the exposure response and current exposure in
a population to produce a numeric estimate of
the risk. There are speciﬁc components of the
process that might be particularly important
for occupational cancer risk assessment.
Better integration of animal and human
studies. Too often, animal and human research
are not formally or effectively linked to address
unknown factors in occupational cancer.
Ideally, animal and human studies should be
better coordinated using results of each to
inform the other. At present, the most impor-
tant need, paradoxically, is to explore in labo-
ratory studies the markers and mechanisms of
agents for which the carcinogenicity in
humans is well established. The relationships
between laboratory indices and human effects
will establish the paradigm for future hazards
identiﬁed in laboratory studies. The ability to
identify similar biological pathways, or modes
of action, in different species will be critical to
this process. For example, markers of interme-
diate cancer-related end points, metabolism,
or noncancer related toxicity can be examined
interactively in animal and in human studies,
then conﬁrmed in large-scale human studies.
Approaches should also be developed to foster
collaboration between scientists who study
cancer in humans and scientists who carry
out cancer studies in animals. When expo-
sure–response data are available from human
studies, they should be used in the risk assess-
ment process (Samet et al. 1998).
Incorporating mechanistic information in
cancer risk assessments. Risk assessment models
that link advances in knowledge of the cancer
process from both experimental and epidemio-
logic studies into an overall assessment should
be further developed and validated. Currently,
little modeling of animal bioassay data, and
even less modeling of human data, incorporate
these advances. Furthermore, human and ani-
mal studies are modeled separately; both types
of models are relatively simplistic, and in gen-
eral are not even consistent with each other.
Federal regulatory agencies typically ﬁt animal
cancer bioassays with risk assessment models in
which the chemical’s risk is additive to back-
ground and not a function of age, whereas
human studies are most often ﬁt with relative-
risk models, in which the relative risk due to
chemical exposure is usually a function of age
and other covariates. Better integration of ani-
mal and human cancer incidence and mecha-
nism studies is needed, as well as better
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information. These models might be viewed to
some extent as extensions of the original
Armitage and Doll (1954) multistage model
for cancer (inherently a relative-risk model),
and should incorporate information, such as
target tissue dosimetry, speciﬁc oncogene acti-
vation, tumor-suppressor gene deactivation,
and promoter mechanisms, as available.
The use of multistage theory as a starting
point and the incorporation of gene activa-
tion/deactivation and similar information
highlights the importance of developing and
validating models that specify the target
organ, with corresponding time-dependent
estimates of target organ dose. This would
require further research into historical back-
ground rates and physiologically based phar-
macokinetic (PBPK) models, respectively.
It is also important to take into account
interindividual variations in susceptibility and
sensitivity to cancer induction, especially when
such variations have a genetic basis. The explo-
sion of genetic information in recent years may
allow for risk assessments based on a combina-
tion of susceptibility information and exposure
data. Also needed are new approaches to using
data on mechanism of action to reduce uncer-
tainties in cancer risk assessments. These
approaches should include sensitivity analysis
to identify model parameters that need experi-
mental data to reduce major uncertainties in
occupational risk assessments.
In addition to genetic differences in sensi-
tivity, cultural or individual behavioral factors
may affect a person’s exposure or response to
occupational carcinogens. New cancer risk
assessment models should account for such
differences. For example, models are needed
to account for interactions between occupa-
tional respiratory carcinogens and cigarette
smoking, a personal risk factor which is pre-
sent in 30% of the U.S. population and is
estimated to account for approximately 40%
of U.S. cancer mortality and more than 90%
of U.S. lung cancer mortality. Similarly, alco-
hol consumption has been associated with
esophageal and liver cancer, so studies of chem-
icals thought to affect those organs should look
at potential synergistic effects of alcohol.
Models considering potential interaction
between workplace exposure to initiating and
promoting substances, or in the human diet or
with infectious agents, should also be consid-
ered. The development of these models may
require data from a testing program that
includes joint administration of tobacco smoke,
alcohol, a diet (i.e., high fat, enriched with ﬁber
or vitamins) along with the carcinogens being
tested. Cancer risk assessment models should
also be developed for chemical mixtures or pro-
duction processes most common in industry or
involving the most people. Alternative models,
and the hypotheses underlying them, should be
validated to ensure that they produce more reli-
able estimates of risk than the standard models.
Just as new cancer models need to be
developed and validated, regulatory agencies
need to develop guidelines for their applica-
tion consistent with regulatory policies and
authority. Ultimately, the utility of risk
assessments will be judged on how well they
lead to effective risk management and cancer
prevention decisions. More research is needed
on how this type of information is communi-
cated to managers, decision makers, and the
public, how it is used, and how it can be
improved (Paustenbach 1995).
Prevention
Methods for primary prevention. Primary
prevention of cancer can be accomplished in
two ways: by avoiding the introduction of
carcinogenic agents into the environment and
by eliminating or drastically reducing expo-
sure to carcinogenic agents that are already in
the environment (Tomatis et al. 1997). For
many industrial processes, reduction of expo-
sure to carcinogenic agents in the workplace
can be achieved using established technology,
while for others, more innovative methods
are needed and should be a priority for future
research. There should be greater emphasis
on designing industrial processes to eliminate
exposure to potential carcinogens. For exam-
ple, chemists and engineers should plan “safe”
reactions and processes at the research stage
before reactions are scaled up for pilot plant
and, ultimately, full-scale production. Such
planning requires knowledge of the possible
carcinogenicity of by-products and intermedi-
ates, as well as the desired product, and
should take advantage of advances in com-
puter modeling and prediction of toxicologic
potential. Research on less hazardous substi-
tutes for processes that produce or otherwise
involve carcinogens should be directed by
considerations of cancer risk to workers as
well as chemical or engineering needs.
As a number of known and suspected car-
cinogens are already in use, research is needed
to develop methods to reduce exposure to
these carcinogens. This is part of the public
health approach that recommends that engi-
neering controls to reduce or, preferably,
eliminate exposure, should be the primary
prevention strategy (Weeks et al. 1991).
Although this approach has been imple-
mented in a number of industries, further
research is needed to develop practical and
affordable engineering controls to reduce
exposures to carcinogens. Despite the desir-
ability of such engineering controls, use of
personal protective equipment may be needed
in some settings. Research on more effective
and practical personal protective equipment is
thus needed. Efforts to reduce occupational
exposure should be coupled with efforts to
eliminate transport of toxic substances outside
the workplace.
The importance of dermal exposures in the
workplace is increasingly being recognized.
Research is needed to prevent such exposures,
including primary source reduction, engineer-
ing controls, and better protective equipment.
For example, the use of whole-body protection
and gloves to prevent dermal exposure may be
associated with adverse effects (heat stress, der-
matitis), and substantial gaps exists in knowl-
edge about the efﬁcacy of their use to prevent
dermal exposure.
As most carcinogens exhibit a dose–
response relationship, a simple corollary is that
low exposures are likely to result in low excess
risk and that lowering of exposure levels will
result in a reduction of risk (Tomatis et al.
1997). Research is necessary to evaluate the
translation of knowledge on carcinogenicity
and methods to reduce exposure to preventive
measures and the efficacy of such measures.
Methods development needs include tools to
evaluate organizational decision making
with regard to exposure controls, as well as
improved tools to evaluate the protective
effects of exposure reduction, including bio-
markers of exposure and intermediate effect.
Methods for secondary prevention. More
than 3 million U.S. workers are estimated to
have potential occupational exposure to agents
and mixtures substances classiﬁed by IARC as
Group 1 (carcinogenic to humans) or Group
2A (probably carcinogenic to humans) and by
the NTP as known human carcinogens or rea-
sonably anticipated to be human carcinogens
[estimates of the numbers of workers exposed
are derived from NOES data reported in the
Ninth Report on Carcinogens (NTP 2000)].
Countless more have had such exposures in the
past. Secondary interventions may be applica-
ble for some workers with potential exposure to
occupational carcinogens. The study of popula-
tions at increased risk of cancer due to work-
place exposures to carcinogens can provide
important information about cancer prevention
strategies. Conducting medical intervention
studies in occupational rather than in general
population cohorts can reduce the number of
subjects needed to obtain adequate statistical
power (because of higher incidence of disease in
the worker group), as well as facilitate identiﬁca-
tion of potential subjects and stratiﬁcation on
potential risk (exposure) characteristics. Also,
causal relationships and underlying mechanisms
might be more clearly identiﬁed when focusing
on groups with similar exposures.
Despite what would appear to be great
advantages of using high-risk cohorts in inter-
vention research and the potential to develop
effective preventive strategies for occupation-
ally related cancer, only a limited number of
such studies have been done (Tomatis 2000).
Traditional and molecular epidemiologic
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which secondary prevention interventions
could be most effective (Perera 2000; Schulte
et al. 1998). Consideration should be given to
how best to incorporate such high-risk popu-
lations into future occupational cancer
research. In order for high-risk persons to ini-
tiate appropriate secondary prevention, they
must be made aware of their risks and
options. Although NIOSH has made pio-
neering efforts in the notiﬁcation of high-risk
cohorts, much occupational cancer research
may still be performed without provisions for
notifying cohort members of the study’s ﬁnd-
ings, and only limited data are available on
the impact of notification programs or the
design of notification materials (Boal et al.
1995). Evaluative research is needed to ensure
that the goals of notification, to inform and
to provide recommendations for reducing
risk, are being achieved by existing programs.
Once cohort members are notiﬁed, more
specific interventions need to be examined,
particularly the use of chemicals to suppress
the carcinogenic process (i.e., chemopreven-
tion). This area deserves additional, albeit cau-
tious, investigation in high-risk occupational
cohorts. In particular, proposed interventions
should be based on specific, demonstrated,
biological principles to increase the likelihood
of a positive effect. Studies should incorporate
intermediate biomarkers that can monitor the
effect on key steps in the biological pathways
leading to cancer. Levels of mutant p53 pro-
tein in serum of workers exposed to vinyl
chloride may represent such a marker (Trivers
et al. 1995).
Although research in occupational cohorts
has great promise to yield information about
the efﬁcacy of medical screening and interven-
tion to reduce cancer risk, as well as scientiﬁc
knowledge about the carcinogenesis of agents,
these cohorts should be viewed as vulnerable
populations. Researchers following high-risk
cohorts should take special care to balance the
rights and medical surveillance needs of par-
ticipants with the objectives of the research
(Samuels 1998). Ethical issues related to such
studies need critical and ongoing attention,
especially in relation to the implications of
new research ﬁndings in prospective studies.
Conclusions
Four areas of methodologic development have
been identiﬁed to enhance occupational cancer
research and prevention. These include new
ways to identify carcinogens, strengthen epi-
demiologic research and risk assessment, and
strategies for prevention. Recommendations in
each of these areas are shown in Table 1. In
particular, further work is needed on methods
to address cancer risks from chemical mixtures.
The major theme of the recommendations is
that traditional approaches to occupational can-
cer research can be strengthened by the integra-
tion of human, animal, and other biological
data in planning research and conducting risk
assessments. Research on occupational cancer
needs to be approached as an interdisciplinary
process. Less expensive ways of screening new
substances for potential carcinogenicity must be
developed and applied before or early in their
commercial use. The Ames-Salmonella test
works reasonably well for genotoxic agents;
screening for nongenotoxic agents is problem-
atic. The increasing difﬁculty in ﬁnding popu-
lations with suitable exposure history and
characteristics for inclusion in epidemiologic
studies requires reﬁnement in exposure assess-
ment and consideration of study designs that
use intermediate biomarkers to examine mode
of action in humans, as well to estimate expo-
sure and detect early disease.
Research is also a needed on better appli-
cations of existing or new knowledge for pri-
mary prevention. In this article we focus on
chemical agents, fibers, and particulates,
which along with ionizing radiation are con-
sidered the primary causes of occupational
cancer. Additional review is needed to address
the individual and interactive roles of other
physical agents, as well as biological agents
and psychological factors related to work.
Some of these other potential risk factors have
Commentaries • National Occupational Research Agenda Team
10 VOLUME 111 | NUMBER 1 | January 2003 • Environmental Health Perspectives
Table 1. Recommendations to enhance occupational cancer research methods.
Area Recomendations
Identiﬁcation of occupational carcinogens Improve workplace exposure assessment and characterization for 
prioritization of carcinogenicity testing
Improve simulation of occupational exposure circumstances for 
experimental studies
Develop new strategies for predicting and testing the adverse effects
of mixtures
Develop and validate experimental and computational methods for
better hazard identiﬁcation and characterization of exposure–response
relationships
Accelerate testing of priority compounds for carcinogenicity
Epidemiologic research in occupational Improve methods to:
cancer Characterize extent of occupational and environmental exposures
by all routes
Identify populations for study
Estimate levels of exposure retrospectively
Conduct surveillance of occupationally related cancer
Identify, validate, and utilize biological markers as surrogate 
end points
Determine the relationship between maternal and paternal
occupational exposure and cancer in offspring
Increase emphasis on:
Prospective studies with collection of biological samples and
use of archival samples
Multicenter case–control studies
Applying advances in genetic research to better understand the
etiology of occupational cancer and the basis for interindividual 
differences in susceptibility
Studies of occupational cancer in women and minorities
Improvements in risk assessment for  Develop approaches to foster collaborations between human and
occupational carcinogens animal researchers by:
Improving communication and interaction
Integrating modes and mechanisms
Set national priorities
Develop and validate risk assessment models by incorporation of 
modes and mechanisms of action (biomarkers):
Use biologically based risk models for hypothesis framing and 
testing
Use mechanisms to reduce uncertainty factors
Study sensitive subpopulations and lifestyles
Explore improved methods of communicating risk assessment 
information to risk managers, decision makers, and the public
Prevention of occupational cancers Emphasize methods for primary prevention through elimination or 
reduction of exposure to suspected carcinogens, which will include:
Greater emphasis on front-end designs to reduce exposures in
industrial processes
Research on effective prevention of primary exposures
Research on effective communication of prevention strategies
Enhance methods for secondary prevention through:
Intervention research in high risk occupational cohorts that includes 
screening studies, early diagnosis and treatment (chemoprevention)
Inclusion of high-risk occupational cohorts in future cancer research
Evaluate high-risk notiﬁcation and intervention programs
Address ethical issues of secondary prevention studiesnot been addressed in this article because of
the limited information available. The aging of
the U.S. workforce will result in an increased
incidence of cancer. The role that work plays
in affecting the availability and use of diagno-
sis, treatment, and rehabilitative services
should be a focus for research.
More effective prevention of occupational
cancers can be accomplished by improving
the methods used in occupational cancer
research. In this article we have suggested an
agenda for those improvements.
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